These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 8657627

  • 1. [Pentoxifylline].
    Paradowski PT, Zeman K.
    Postepy Hig Med Dosw; 1995; 49(2):201-20. PubMed ID: 8657627
    [Abstract] [Full Text] [Related]

  • 2. Phosphodiesterase inhibition decreases nuclear factor-kappaB activation and shifts the cytokine response toward anti-inflammatory activity in acute endotoxemia.
    Coimbra R, Melbostad H, Loomis W, Tobar M, Hoyt DB.
    J Trauma; 2005 Sep; 59(3):575-82. PubMed ID: 16361898
    [Abstract] [Full Text] [Related]

  • 3. Pentoxifylline: a drug with wide spectrum applications in dermatology.
    Zargari O.
    Dermatol Online J; 2008 Nov 15; 14(11):2. PubMed ID: 19094840
    [Abstract] [Full Text] [Related]

  • 4. Pentoxifylline.
    Samlaska CP, Winfield EA.
    J Am Acad Dermatol; 1994 Apr 15; 30(4):603-21. PubMed ID: 8157787
    [Abstract] [Full Text] [Related]

  • 5. Suppressive effects of pentoxifylline on natural killer cell activity.
    Reed WR, DeGowin RL.
    J Lab Clin Med; 1992 Jun 15; 119(6):763-71. PubMed ID: 1593221
    [Abstract] [Full Text] [Related]

  • 6. Effects of pentoxifylline on the different steps during adhesion and transendothelial migration of flowing neutrophils.
    Bahra PS, Rainger GE, Wautier JL, Nash GB.
    Cell Biochem Funct; 2001 Dec 15; 19(4):249-57. PubMed ID: 11746205
    [Abstract] [Full Text] [Related]

  • 7. [New aspects of the pharmacology of pentoxifylline].
    Lenoble Giovannangeli M.
    J Mal Vasc; 1989 Dec 15; 14 Suppl A():35-41. PubMed ID: 2654314
    [Abstract] [Full Text] [Related]

  • 8. The phosphodiesterase inhibitors pentoxifylline and rolipram suppress macrophage activation and nitric oxide production in vitro and in vivo.
    Beshay E, Croze F, Prud'homme GJ.
    Clin Immunol; 2001 Feb 15; 98(2):272-9. PubMed ID: 11161985
    [Abstract] [Full Text] [Related]

  • 9. Effect of pentoxifylline on tumor necrosis factor-alpha and interleukin-6 levels in neonatal sepsis.
    Selim K, Hüseyin C, Ibrahim KH, Hasan BU, Kazim U, Hüseyin K.
    Med J Malaysia; 2004 Aug 15; 59(3):391-4. PubMed ID: 15727386
    [Abstract] [Full Text] [Related]

  • 10. Effect of activators and the phosphodiesterase inhibitors pentoxifylline and enoximone on the deformability of neutrophils in neonates and adults.
    Ruef P, Poeschl JM, Simon C, Altfelder F, Craciun E, Linderkamp O.
    Acta Paediatr; 2004 Oct 15; 93(10):1288-93. PubMed ID: 15499946
    [Abstract] [Full Text] [Related]

  • 11. Effect of pentoxifylline on polarization and migration of human leukocytes.
    Domínguez-Jiménez C, Sancho D, Nieto M, Montoya MC, Barreiro O, Sánchez-Madrid F, González-Amaro R.
    J Leukoc Biol; 2002 Apr 15; 71(4):588-96. PubMed ID: 11927644
    [Abstract] [Full Text] [Related]

  • 12. Pentoxifylline suppresses renal tumour necrosis factor-alpha and ameliorates experimental crescentic glomerulonephritis in rats.
    Chen YM, Ng YY, Lin SL, Chiang WC, Lan HY, Tsai TJ.
    Nephrol Dial Transplant; 2004 May 15; 19(5):1106-15. PubMed ID: 14993492
    [Abstract] [Full Text] [Related]

  • 13. Pentoxifylline and its major oxidative metabolites exhibit different pharmacological properties.
    Fantin M, Quintieri L, Kúsz E, Kis E, Glavinas H, Floreani M, Padrini R, Duda E, Vizler C.
    Eur J Pharmacol; 2006 Mar 27; 535(1-3):301-9. PubMed ID: 16545799
    [Abstract] [Full Text] [Related]

  • 14. Synergistic immunomodulatory effects of interferon-beta1b and the phosphodiesterase inhibitor pentoxifylline in patients with relapsing-remitting multiple sclerosis.
    Weber F, Polak T, Günther A, Kubuschok B, Janovskaja J, Bitsch A, Poser S, Rieckmann P.
    Ann Neurol; 1998 Jul 27; 44(1):27-34. PubMed ID: 9667590
    [Abstract] [Full Text] [Related]

  • 15. Pentoxifylline prevents the meglumine antimonate-induced renal toxicity in rats, but not that induced by the inorganic antimony pentachloride.
    de Moura FJ, Leal PP, de Souza Furtado R, Muniz-Junqueira MI, Veiga JP.
    Toxicology; 2008 Jan 14; 243(1-2):66-74. PubMed ID: 18022309
    [Abstract] [Full Text] [Related]

  • 16. Inhibitory effects of pentoxifylline on ultraviolet B light-induced cutaneous inflammation.
    Oberyszyn TM, Tober KL, Ross MS, Robertson FM.
    Mol Carcinog; 1998 May 14; 22(1):16-25. PubMed ID: 9609097
    [Abstract] [Full Text] [Related]

  • 17. Pentoxifylline inhibits leukocyte infiltration and splenocyte cytotoxicity against murine colon adenocarcinoma.
    Lazarczyk M, Grzela T, Niderla J, Golab J, Korczak-Kowalska G, Oldak M, Skopinski P.
    Oncol Rep; 2003 May 14; 10(4):839-43. PubMed ID: 12792732
    [Abstract] [Full Text] [Related]

  • 18. Neutrophil degranulation and the effects of phosphodiesterase inhibition.
    Deree J, Lall R, Melbostad H, Grant M, Hoyt DB, Coimbra R.
    J Surg Res; 2006 Jun 01; 133(1):22-8. PubMed ID: 16690368
    [Abstract] [Full Text] [Related]

  • 19. Influence of pentoxifylline on perforin expression in human PBMC.
    Lazarczyk M, Grzela T, Niderla J, Dziunycz P, Milewski L, Lazarczyk MA, Samaha R.
    Int J Mol Med; 2004 Oct 01; 14(4):725-8. PubMed ID: 15375608
    [Abstract] [Full Text] [Related]

  • 20. Pentoxifylline ameliorates pulmonary damage caused by Streptococcus pneumoniae infection in mouse.
    Cui X, Zhang R, Fu W, Cao Z.
    Chin Med J (Engl); 1995 Nov 01; 108(11):864-9. PubMed ID: 8585982
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.